Available Until 4/23/2023

A Proactive, Patient-Centered Approach to Managing Immune-Related Adverse Events


ACPE Activity Number: 0204-0000-21-434-H01-P
Release Date: January 20, 2022
Expiration Date: April 23, 2023
Activity Type: Application-based
CE Credits: 1.5 contact hours (0.15 CEUs)
Activity Fee: Members – Free / Non-Member – Free

 This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview

This case-based educational activity will include an overview of immune checkpoint inhibitors, their mechanisms of action and adverse effects, current and expanding indications, and strategies for early recognition, effective management and best practices for patient education and monitoring.

Expert Insights

The Pharmacist as Immunotherapy Educator: Focus on the Human Factor
Read now →

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The target audience for this educational activity is pharmacists who practice in hospitals, health systems, and ambulatory clinics who care for patients treated with immune checkpoint inhibitors.

Learning Objectives

At the conclusion of this activity, participants will be able to:

  • Discuss the mechanisms of action of immune checkpoint inhibitors and how these cause immune-related adverse events (irAEs) during treatment for cancer indications.
  • Describe irAEs seen in patients treated with immune checkpoint inhibitors, with a focus on affected organ systems, time course for symptoms, and clinical presentation.
  • Develop practice site-specific best practices for the prevention and management of irAEs, including patient education, recognition, treatment, and monitoring.

  • Welcome and Introductions
  • Presentations and Discussion
  • Faculty Discussion/ Questions and Answers

Jordan McPherson, Pharm.D., M.S., BCOP, Activity Chair
Oncology Clinical Pharmacist
Huntsman Cancer Institute
Adjunct Assistant Professor
University of Utah College of Pharmacy
Salt Lake City, Utah

Jordan McPherson, Pharm.D., M.S., BCOP is Oncology Clinical Pharmacist in the ambulatory solid tumor clinics at the Huntsman Cancer Institute, an NCI designated cancer hospital, at the University of Utah Health and Adjunct Assistant Professor at the University of Utah College of Pharmacy in Salt Lake City, Utah. Dr. McPherson specializes in the treatment of skin cancer using immunotherapy and other targeted therapies. He serves as a Panelist on the NCCN Guidelines for Management of Immune Checkpoint Inhibitor-Related Toxicities, and is Past President of the Utah Society of Health-System Pharmacists. Dr. McPherson’s research efforts are well published in peer reviewed journals, including the Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, and Pharmacotherapy.

Tonya Smith, Pharm.D., BCPS
Clinical Pharmacy Specialist, Internal Medicine
Emory University Hospital Midtown
Atlanta, Georgia

Tonya Smith, Pharm.D., BCPS, is Clinical Pharmacy Specialist in Internal Medicine at Emory University Hospital Midtown in Atlanta, Georgia. Dr. Smith received her Pharm.D. degree from the Medical University of South Carolina in Charleston, South Carolina. She completed her PGY1 Pharmacy Practice Residency and PGY2 Internal Medicine Pharmacy Residency at University of Utah Health in Salt Lake City, Utah. Prior to Emory, Dr. Smith practiced on the inpatient medical oncology service and the Supportive Oncology & Survivorship Clinic at the Huntsman Cancer Institute in Salt Lake City, Utah.

Relevant Financial Relationship Disclosure

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CPE activity.

This activity consists of a recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP eLearning Portal. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Claim your CE at http://elearning.ashp.org. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.

Supported by an independent medical education grant from Merck, Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme